Objective: This study evaluated the efficacy of middle meningeal artery (MMA) embolization for organized chronic subdural hematoma (OCSDH).
Introduction
Many cases of chronic subdural hematoma (CSDH) are curable by burr-hole surgery (BHS) or less-invasive surgery using a twist-drill under local anesthesia, whereas recurrence and the organized chronic subdural hematoma (OCSDH) after BHS come across at a specific rate. 1) Because of insufficient reduction of the mass effect, OCSDH often requires craniotomy to remove residual hematoma. 2) However, craniotomy with removal of hematoma under general anesthesia in OCSDH is highly invasive, so some cases lead to the unfavorable postoperative prognosis. 2) In this study, embolization of the middle meningeal artery (MMA) under local anesthesia was performed for OCSDH and the usefulness of this treatment was investigated.
Subjects
During a 5-year period from 2013 to 2017, 282 cases with CSDH (314 lesions, bilateral in 32 patients) were treated with BHS at our institution and relevant medical institutions. In all, 32 cases (39 lesions [12. 4%], bilateral in seven cases) were recurrent. These recurrent lesions were treated with BHS and small craniotomy, but the hematoma could not be sufficiently removed in some cases. Eleven cases (14 lesions [4.5%] , bilateral in three cases) were diagnosed as OCSDH, and treated with MMA embolization. The case population comprised seven men (10 lesions) and four women (four lesions) with a mean age of 73.8 years (range, 60-88 years). Six lesions were located on the left side, and eight lesions were located on the right one ( Table 1) . OCSDH was diagnosed following previous reports. 2, 3) It was defined as follows: 1) hematoma which could not be sufficiently removed by BHS or small craniotomy with 2) heterogeneous density hematoma on postoperative CT or 3) multilayered septum and heterogeneous residual hematoma on both MRI T1-and T2-weighted imaging, or 4) homogenous residual hematoma without high-intensity components on both MRI T1-and T2-weighted imaging. Even though multilayered septum were present, the cases of sufficient removal of hematoma under BHS were excluded.
On the initial surgery, eight cases presented with cortical focal symptoms or hemiparesis, one case showed disturbance of consciousness, one case developed an epileptic seizure, and one case developed aggravating headache. Nine lesions demonstrated multilayered septum or high-density area in the hematoma and the other four lesions were homogenous hematoma on head CT.
Methods
In all cases, BHS was performed under local anesthesia on the initial surgery. At the time of showing the hematoma with symptomatic regrowth, BHS and small craniotomy were performed for second surgery. After OCSDH was diagnosed, MMA embolization was applied to these lesions with a 3 mm or larger regrowth on follow-up head CT.
MMA embolization was performed under local anesthesia without systemic heparinization. First, a 6Fr sheath was placed in the femoral or brachial artery, and a 6Fr guiding catheter was guided to the origin of the external carotid artery through the trans-femoral or trans-brachial approach. After confirming the absence of dangerous anastomosis on super-selective angiography of the MMA, the microcatheter was advanced to the MMA branch with abnormal vascular networks. Then, the target MMA branch was embolized with polyvinyl alcohol particles (PVA) or trisacryl gelatin microspheres (TGM). Embolization was finished after stagnation of blood flow in the target MMA branch was confirmed.
Residual hematoma after MMA embolization were assessed into three clinical states on head CT: 1) state of complete hematoma regression was assessed as complete resolution, 2) residual hematoma thickness of 50% or less was assessed as partial resolution, and 3) residual hematoma thickness of more than 50% or the absence of size reduction was assessed as insufficient effect. In addition, the period to reduce 3 mm or more hematoma after MMA embolization, procedure-associated complications, and preventive effect of regrowth were investigated. Table 2 shows the treatment results of the 14 lesions. The mean interval from the first treatment to recurrence was 4.7 weeks (2-10 weeks). BHS was performed for 12 lesions and 2 lesions additionally required small craniotomy under local anesthesia as second treatment. In all, 11 lesions were treated with MMA embolization when regrowth of residual hematomas were revealed during postoperative course, and three lesions were treated at the same period. Embolic materials were used in five lesions of PVA, and nine lesions of TGM.
After MMA embolization, size reduction of the subdural hematoma was noted in 12 lesions within 2.9 weeks on average (2-4 weeks). Of these lesions, eight lesions assessed complete resolution, and four lesions (Cases 4, 5, 10, and 11) assessed partial resolution. No recurrence was noted throughout the follow-up period (6-24 months, mean duration: 11.9 months) in these 12 lesions. Two cases (Cases 3 and 9) assessed insufficient effect, which presented severe mass effects at the recurrence on head CT. These cases got aggravation of neurological symptoms after the MMA embolization, and required craniotomy under general anesthesia. In Case 3, small craniotomy was performed but sufficient decompression could not be obtained. Although MMA embolization was performed, neurological symptoms aggravated, so craniotomy was performed under general anesthesia. In Case 9, regrowth of the hematoma was noted after MMA embolization. Craniotomy was performed, and infectious subdural hematoma was suggested in the operative finding. No procedure-associated complication occurred, but wound healing after BHS was delayed in one case (Case 4).
Case presentations
Case 8: 85-year-old male Past medical history: hypertension, cerebral infarction (being treated with oral clopidogrel)
The patient presented with headache, and head CT revealed right CSDH, and it was decided to perform BHS for aggravating headache.
Head CT revealed right fronto-parietal heterogeneous hematoma with multilayered septum and midline shift toward the left side (Fig. 1A) .
BHS was performed under local anesthesia, 120 mL of hematoma was removed, and headache rapidly resolved (Fig. 1B) . After 3 weeks, headache and gait disturbance appeared and recurrence of right CSDH was demonstrated on head CT (Fig. 1C) . Second BHS was performed, but only 45 mL of hematoma could be removed, and residual homogenous iso-density hematoma was demonstrated on postoperative head CT; therefore, the lesion was diagnosed as OCSDH (Fig. 1D) . Headache was persisted thereafter, MMA embolization was performed to prevent regrowth.
A 6Fr guiding catheter (Envoy; Codman, Raynham, MA, USA) was placed in the right external carotid artery, and a microcatheter (Excelsior SL-10; Stryker Neurovascular, Fremont, CA, USA) was guided to the right MMA. Abnormal vascular networks were confirmed under super-selective angiography through the MMA (Fig. 1E) , and the microcatheter was advanced to a more peripheral site and embolization with 100-300 µm TGM (Embosphere; Nippon Kayaku, Tokyo, Japan) was applied (Fig. 1F) .
Four weeks after MMA embolization, the size of the hematoma begin to decrease. The residual organized component partially remained on CT at 12 months after MMA embolization, but no regrowth has occurred (Fig. 1G) .
Case 9: 80-year-old male Past medical history: Hypertension, diabetes mellitus The patient presented with left hemiparesis, and right CSDH was diagnosed on head CT. Head CT demonstrated a heterogeneous hematoma containing a high-density area and multilayered septum, midline shift toward the left side in the subdural space of the right fronto-parieto-temporal regions ( Fig. 2A) .
BHS was performed under local anesthesia, 160 mL of hematoma was removed, and left hemiplegia improved (Fig. 2B) . Six weeks after initial BHS, left hemiparesis re-developed, and a recurrent homogenous iso-density hematoma was noted on head CT (Fig. 2C) , then second BHS was performed. Only 50 mL of hematoma could be removed, the iso-density hematoma remained on postoperative head CT (Fig. 2D) , and it was diagnosed as OCSDH comprised of heterogeneous components on MRI (Figs. 2E and 2F) . Fever developed on postoperative day 5 and elevation of inflammatory reaction was detected on blood exam (white blood cell [WBC]: 6910/µL, C-reactive protein [CRP]: 8.31 mg/dL), for which antibiotic administration was initiated. The inflammatory reaction improved, but headache developed on postoperative week 2 and slight regrowth of the hematoma was demonstrated on head CT. Thus, MMA embolization was performed under local anesthesia (Fig. 2G-2I) .
Headache did not improve after MMA embolization and further regrowth of the hematoma was demonstrated on head CT (Fig. 2J) . Thus, right fronto-parieto-temporal craniotomy and outer membranectomy was performed 10 days after MMA embolization (Fig. 2K) . The removed infectious subdural hematoma was suggested. Because the patient was treated with antibiotics, the bacteria could not be detected by culture of the hematoma specimen.
Discussion
It was suggested that MMA embolization under local anesthesia for OCSDH may be effective for the reduction of the hematoma size and prevention of the regrowth. OCSDH accounts for 0.5-5.8% of all cases of CSDH and 14% of CSDH cases with recurrence. 3, 4) Pathologically, repeating microhemorrhage from neovessels including macrocapillaries in the OCSDH gradually developed inflammatory granulation and fibrous connective tissue. 4, 5, 6) If BHS alone cannot reduce mass effect and prevent recurrence, craniotomy was required in many cases. 2, 3, 4) It has been reported that recurrence occurred in 8-37% despite craniotomy, 2) hence various surgical treatment, such as hematoma removal by extensive craniotomy with membranectomy and dura-inner membrane adhesion, have been performed to improve curability. 6, 7, 8) However, invasive surgery under general anesthesia does not necessarily improve postoperative prognosis depending on the general condition and concomitant diseases. In the elderly patients, general anesthesia and surgical stress may cause the unfavorable states, such as convulsive seizure and reduction of cognitive function. Recently, endoscopy-assisted surgery under local anesthesia for OCSDH has been reported, 9, 10, 11) but it requires strict management of sedation and the procedure has not yet been established.
It has been reported that the recurrence rate after MMA embolization under local anesthesia was 1.4-10.4% for refractory CSDH, 3, 12, 13) still the efficacy of MMA embolization for OCSDH has not been reported. Conversely, Chihara et al. reported an ineffective case which recurred 3 months after MMA embolization with 250-355 µm PVA. 14) They described that neovessels may have developed in the 3-month period, and led to the recurrence on the basis of pathological examination of removed hematoma by craniotomy. However, in our study, reduction of hematoma size and prevention of regrowth were seen in 12 of the 14 lesions.
microhemorrhage from neovessels occurs mainly in the rough parts. 5, 15, 16) They suggest that inflammatory reactions associated with microhemorrhage promote thickening of the hematoma capsule and organization.
Therefore, the efficacy of MMA embolization for OCSDH was considered as follows: MMA embolization for the stage of repeating microhemorrhage, such as the mature and progressive stages, induced to suppress the microhemorrhage and organized inflammation, and reduced the hematoma size in the resolving stage. Thus, in the resolving stage, size reduction may have started from the rough parts As above, the efficacy of MMA embolization for OCSDH can be expected, in which the therapeutic indication and timing of MMA embolization may be important factors.
Regarding the development process of CSDH, Takahashi et al. 15) classified it into five clinical stages (initial stage, premature stage, mature stage, progressive stage, and resolving stage). Hematoma increases in the mature and progressive stages, thereafter the size decreases in the resolving stage. Although the developing OCSDH has not been clarified, it has been reported that fibroblast and fibrin components were mixed on rough parts and dens parts; furthermore, When the time to appearance of the treatment effect after MMA embolization was investigated, hematoma slightly enlarged immediately after embolization in some lesions, but all lesions stopped enlargement within 2 weeks. That was similar to non-organized recurrent CSDH. 17) While our 12 cases of OCSDH take longer period to sufficiently decrease the mass effect, and organized components partially remained in four lesions. Therefore, it takes long time to improve neurological deficit, so craniotomy may be required in cases of OCSDH with severe mass effect. Moreover, in thick OCSDH, such as Case 3, neovessels may be present extensively and deeply in the organized hematoma. In these lesions, the embolic material may insufficiently reach to the periphery, which lead to development of neovessels and regrowth of hematoma later.
Even though coils and large particles were used, as embolic materials, embolization of the proximal MMA may be effective in lesions with less collateral circulation, but it is difficult to confirm the collateral circulation. 18, 19) Thus, to obtain sufficient embolization, it is desirable to advance a microcatheter to more peripheral vessels and use n-butyl-2-cyanoacrylate (NBCA) or small size particles. However, attention to dangerous anastomosis should be needed. 14) Low-concentration NBCA also may be useful for OCSDH because wedged catheter and heated lipiodol make NBCA to improve reachability. 20) While NBCA cannot necessarily reach the periphery in any cases, and MMA embolization with NBCA required strict sedation equivalent to general anesthesia and reduction of inflammatory pain after embolization. For this complexity, PVA or TGM is selected in our institution. However, it is carefully even though embolization with particles appears complete, the embolic material may not reach sufficiently peripheral vessels. In such cases, neovessels may be developed, and caused regrowth of the residual hematoma. Thus, long-term follow-up is necessary after MMA embolization.
Infection of OCSDH is rare, but once it occurs, it is difficult to cure by administration of antibiotics alone and craniotomy is necessary in many cases. 21, 22, 23) In Case 9 suspected as infectious subdural hematoma, MMA embolization caused reduction of blood flow to the hematoma capsule, and may decrease effect of antibiotics to the hematoma. Thus, if there is any suspect that the lesion is infectious subdural hematoma, MMA embolization should be strictly avoided.
For the patients difficult to treat with invasive surgery under general anesthesia, such as the elderly, mass reduction and alleviation of symptoms may improve the activities of daily living, even though organized components partially remained. Thus, it may not be necessary to select invasive curative treatment. However, when severe neurological symptoms and epileptic seizures remain due to residual hematoma, craniotomy should be desirable.
Conclusion
MMA embolization under local anesthesia may be an effective additional modality for OCSDH with regrowth after decompression of BHS and small craniotomy.
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